MaxCyte, Inc. (MXCT)
NASDAQ$3.29
Market Cap
$348.83M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
182 of 924
Rank in Industry
20 of 118
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
MXCT Insider Trading Activity
MXCT Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $489,066 | 2 | 9 |
Sells | $1,135,961 | 21 | 91 |
Related Transactions
| Masoud Maher | President and CEO | 2 | $489,066 | 0 | $0 | $489,066 |
| Sandoval David I. | GENERAL COUNSEL | 0 | $0 | 1 | $20,272 | $-20,272 |
| Johnston John Joseph | director | 0 | $0 | 10 | $148,913 | $-148,913 |
| Ross Thomas M. | EVP, GLOBAL SALES | 0 | $0 | 5 | $418,967 | $-418,967 |
| Erck Stanley C | director | 0 | $0 | 5 | $547,810 | $-547,810 |
About MaxCyte, Inc.
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. …
Insider Activity of MaxCyte, Inc.
Over the last 12 months, insiders at MaxCyte, Inc. have bought $489,066 and sold $1.14M worth of MaxCyte, Inc. stock.
On average, over the past 5 years, insiders at MaxCyte, Inc. have bought $16.03M and sold $15.33M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Masoud Maher (President and CEO) — $489,066.
The last purchase of 70,443 shares for transaction amount of $345,241 was made by Masoud Maher (President and CEO) on 2024‑06‑10.
List of Insider Buy and Sell Transactions, MaxCyte, Inc.
| 2025-01-27 | Sale | Johnston John Joseph | director | 3,000 0.0029% | $4.64 | $13,935 | -12.06% | |
| 2025-01-13 | Sale | Sandoval David I. | GENERAL COUNSEL | 4,466 0.0039% | $4.54 | $20,272 | -15.38% | |
| 2024-12-26 | Sale | Johnston John Joseph | director | 3,000 0.0028% | $4.01 | $12,021 | +2.33% | |
| 2024-12-09 | Sale | Johnston John Joseph | director | 2,495 0.0021% | $3.79 | $9,459 | +0.48% | |
| 2024-12-06 | Sale | Johnston John Joseph | director | 505 0.0005% | $3.70 | $1,869 | +16.39% | |
| 2024-11-01 | Sale | Erck Stanley C | director | 47,689 0.0448% | $3.72 | $177,403 | +7.96% | |
| 2024-10-28 | Sale | Johnston John Joseph | director | 3,000 0.0028% | $3.72 | $11,166 | +12.47% | |
| 2024-10-02 | Sale | Erck Stanley C | director | 21,607 0.0196% | $3.71 | $80,162 | +2.94% | |
| 2024-10-01 | Sale | Erck Stanley C | director | 26,082 0.0241% | $3.78 | $98,590 | +3.92% | |
| 2024-09-26 | Sale | Johnston John Joseph | director | 3,000 0.0028% | $3.82 | $11,460 | -1.03% | |
| 2024-09-04 | Sale | Erck Stanley C | director | 29,767 0.0288% | $3.97 | $118,175 | -0.51% | |
| 2024-09-03 | Sale | Erck Stanley C | director | 17,922 0.0171% | $4.10 | $73,480 | -5.13% | |
| 2024-08-26 | Sale | Johnston John Joseph | director | 3,000 0.0028% | $4.28 | $12,840 | -10.16% | |
| 2024-08-02 | Sale | Ross Thomas M. | EVP, GLOBAL SALES | 17,857 0.017% | $4.36 | $77,874 | -9.38% | |
| 2024-08-01 | Sale | Ross Thomas M. | EVP, GLOBAL SALES | 15,476 0.0147% | $4.54 | $70,261 | -13.18% | |
| 2024-07-26 | Sale | Johnston John Joseph | director | 3,000 0.0028% | $4.75 | $14,238 | -16.65% | |
| 2024-07-09 | Sale | Ross Thomas M. | EVP, GLOBAL SALES | 13,531 0.0131% | $4.03 | $54,584 | -2.63% | |
| 2024-07-08 | Sale | Ross Thomas M. | EVP, GLOBAL SALES | 19,802 0.0192% | $4.03 | $79,782 | +0.49% | |
| 2024-06-27 | Sale | Johnston John Joseph | director | 10,000 0.0096% | $3.99 | $39,900 | +1.38% | |
| 2024-06-20 | Sale | Ross Thomas M. | EVP, GLOBAL SALES | 33,333 0.0279% | $4.09 | $136,465 | -2.40% |
Total: 92
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Masoud Maher | President and CEO | 100000 0.0943% | $329,000.00 | 2 | 3 | |
| Casdin Partners Master Fund, L.P. | 10 percent owner | 10000000 9.4315% | $32.9M | 1 | 2 | <0.0001% |
| DOUGLAS RICHARD | director | 100000 0.0943% | $329,000.00 | 2 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
MXCT Institutional Investors: Active Positions
| Increased Positions | 68 | +54.84% | 10M | +14.58% |
| Decreased Positions | 51 | -41.13% | 6M | -8.89% |
| New Positions | 22 | New | 5M | New |
| Sold Out Positions | 22 | Sold Out | 2M | Sold Out |
| Total Postitions | 141 | +13.71% | 73M | +5.69% |
MXCT Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Cadian Capital Management, Lp | $31,210.00 | 8.9% | 9.34M | +1M | +14.11% | 2024-12-31 |
| Blackrock, Inc. | $26,798.00 | 7.64% | 8.02M | -464,667 | -5.47% | 2024-12-31 |
| Vanguard Group Inc | $18,135.00 | 5.17% | 5.43M | -345,587 | -5.98% | 2024-12-31 |
| Vitruvian Partners Llp | $16,845.00 | 4.8% | 5.04M | 0 | 0% | 2024-12-31 |
| Morgan Stanley | $14,724.00 | 4.2% | 4.41M | -408,879 | -8.49% | 2024-12-31 |
| Mirabella Financial Services Llp | $12,358.00 | 3.52% | 3.7M | +4M | New | 2024-12-31 |
| River Global Investors Llp | $10,866.00 | 3.1% | 3.25M | +1M | +57.73% | 2024-12-31 |
| Mudita Advisors Llp | $10,766.00 | 3.07% | 3.22M | +69,966 | +2.22% | 2024-12-31 |
| Fmr Llc | $10,477.00 | 2.99% | 3.14M | +154,222 | +5.17% | 2024-12-31 |
| Millennium Management Llc | $9,155.00 | 2.61% | 2.74M | -1M | -34.63% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.